Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease

被引：14

作者：

Roger, Simon D. ^{[1
]}

机构：

[1] Gosford Hosp, Dept Renal Med, Gosford, NSW, Australia

来源：

CLINICAL KIDNEY JOURNAL | 2017年 / 10卷

关键词：

anaemia; CKD; ESRD; ESA; iron; ERYTHROPOIESIS-STIMULATING AGENTS; RANDOMIZED CONTROLLED-TRIAL; CHRONIC-RENAL-FAILURE; INTRAVENOUS IRON; ORAL IRON; HEMODIALYSIS-PATIENTS; DEFICIENCY ANEMIA; IV IRON; SERUM FERRITIN; SUCROSE;

D O I：

10.1093/ckj/sfx100

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Clinical practice guidelines provide both local and global recommendations for the use of iron therapy in the management of anaemia in patients with chronic kidney disease. However, physicians must interpret and adapt these guidelines to meet the specific needs of their individual patients. The recommendations must also be considered in the context of findings from more recently published clinical trials and observational studies.

引用

页码：9 / 15

页数：7

共 50 条

[21] Ferric citrate in the management of hyperphosphataemia and iron deficiency anaemia: A meta-analysis in patients with chronic kidney disease [J].

Choi, Yeo Jin ;

Noh, Yoojin ;

Shin, Sooyoung .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) :414-426

[22] Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice [J].

Rottembourg, Jacques ;

Rostoker, Guy .

NEPHROLOGIE & THERAPEUTIQUE, 2015, 11 (07) :531-542

[23] Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement [J].

Locatelli, Francesco ;

Barany, Peter ;

Covic, Adrian ;

De Francisco, Angel ;

Del Vecchio, Lucia ;

Goldsmith, David ;

Hoerl, Walter ;

London, Gerard ;

Vanholder, Raymond ;

Van Biesen, Wim .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (06) :1346-1359

[24] Pharmacoeconomic considerations in the health system management of anaemia in patients with chronic kidney disease and end stage renal disease [J].

Brophy, DF ;

Ripley, EBD ;

Holdford, DA .

EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (09) :1461-1469

[25] Anaemia management and mortality risk in chronic kidney disease [J].

Hoerl, Walter H. .

NATURE REVIEWS NEPHROLOGY, 2013, 9 (05) :291-301

[26] New Strategies for Anaemia Management in Chronic Kidney Disease [J].

Locatelli, Francesco ;

Del Vecchio, Lucia .

SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 2017, 189 :184-188

[27] Iron therapy in chronic kidney disease: Recent changes, benefits and risks [J].

Ribeiro, Sandra ;

Belo, Luis ;

Reis, Flavio ;

Santos-Silva, Alice .

BLOOD REVIEWS, 2016, 30 (01) :65-72

[28] Frequency of iron deficiency anaemia in chronic kidney disease patients not on dialysis [J].

Kamil, Faryal ;

Dhrolia, Murtaza ;

Hamid, Aamna ;

Qureshi, Ruqaya ;

Nasir, Kiran ;

Ahmad, Aasim .

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (07) :1396-1400

[29] Association of iron therapy with incidence of chronic kidney disease [J].

Shrestha, Prabin ;

Paul, Shejuti ;

Sumida, Keiichi ;

Thomas, Fridtjof ;

Surbhi, Satya ;

Naser, Abu Mohd ;

Streja, Elani ;

Rhee, Connie M. ;

Kalantar-Zadeh, Kamyar ;

Kovesdy, Csaba P. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) :872-880

[30] Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia) [J].

Jensen, Gert ;

Goransson, Lasse G. ;

Femstrom, Anders ;

Furuland, Hans ;

Christensen, Jeppe H. .

CLINICAL NEPHROLOGY, 2019, 91 (04) :246-253

← 1 2 3 4 5 →